Detalles de la búsqueda
1.
Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170.
Blood
; 142(2): 141-145, 2023 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130017
2.
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Blood
; 138(21): 2031-2041, 2021 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407542
3.
Aspects of laboratory characteristics, analysis of alloimmunization, and searching for predictors related to survival in patients with Autoimmune Hemolytic Anemia.
Transfus Apher Sci
; 62(5): 103741, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37271665
4.
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.
N Engl J Med
; 380(23): 2225-2236, 2019 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31166681
5.
Advanced clinical parameters: A complementary hydroxyurea adherence evaluation in sickle cell anemia treatment.
Eur J Haematol
; 109(6): 736-748, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36048130
6.
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.
Lancet Oncol
; 22(4): 512-524, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721562
7.
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
Lancet
; 395(10232): 1278-1291, 2020 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32305093
8.
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 21(9): 1188-1200, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32888452
9.
Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation.
Ann Hematol
; 97(12): 2269-2278, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315344
10.
BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival.
Cancer Invest
; 2015 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26279306
11.
BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.
Cancer Invest
; 33(9): 451-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26288116
12.
Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma.
Oncol Ther
; 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38829416
13.
Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosome.
Ann Hematol
; 92(2): 185-9, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23064942
14.
Volumetric dried blood microsampling for monitoring imatinib mesylate therapy: Method development and clinical application in patients with chronic myeloid leukemia.
J Pharm Biomed Anal
; 222: 115108, 2023 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36279845
15.
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL.
Leukemia
; 37(3): 617-626, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717654
16.
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study.
Lancet Haematol
; 10(11): e902-e912, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914483
17.
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
JCO Glob Oncol
; 8: e2100265, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35486884
18.
Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia.
EJHaem
; 3(3): 698-706, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36051063
19.
Histoplasma capsulatum sinusitis: case report and review.
Mycopathologia
; 171(1): 57-9, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20635150
20.
Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring.
Hematol Transfus Cell Ther
; 43(2): 191-200, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631809